Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5726
Source ID: NCT00997152
Associated Drug: Jtt-654
Title: Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Type II Diabetes Mellitus
Interventions: DRUG: JTT-654|DRUG: JTT-654 Placebo
Outcome Measures: Primary: Change in Fasting Plasma Glucose (FPG) levels, 3 months | Secondary: Change in glycosylated hemoglobin (HbA1c) levels, 3 months|Effect on glycated albumin, insulin, C-peptide, glucagon and lipid parameters, 3 months|Safety (biochemistry, hematology, urinalysis and adrenal-related markers) and tolerability (adverse events), 3 months
Sponsor/Collaborators: Sponsor: Akros Pharma Inc.
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 152
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2009-09
Completion Date: 2010-04
Results First Posted:
Last Update Posted: 2013-02-04
Locations: Birmingham, Alabama, United States|Chandler, Arizona, United States|Phoenix, Arizona, United States|Tempe, Arizona, United States|Chino, California, United States|Greenbrae, California, United States|Huntington Park, California, United States|Los Angeles, California, United States|Paramount, California, United States|Sacramento, California, United States|Walnut Creek, California, United States|West Covina, California, United States|Deland, Florida, United States|Hialeah, Florida, United States|Hollywood, Florida, United States|Jacksonville, Florida, United States|Miami, Florida, United States|Port Orange, Florida, United States|Marietta, Georgia, United States|Addison, Illinois, United States|Chicago, Illinois, United States|Indianapolis, Indiana, United States|Oxon Hill, Maryland, United States|New Bedford, Massachusetts, United States|Great Falls, Montana, United States|Charlotte, North Carolina, United States|Morehead City, North Carolina, United States|Cincinnati, Ohio, United States|Marion, Ohio, United States|Oklahoma City, Oklahoma, United States|Lansdale, Pennsylvania, United States|Bristol, Tennessee, United States|Carrollton, Texas, United States|Corpus Christi, Texas, United States|Dallas, Texas, United States|Houston, Texas, United States|Katy, Texas, United States|San Antonio, Texas, United States|Sugar Land, Texas, United States|Norfolk, Virginia, United States|Richmond, Virginia, United States|Virginia Beach, Virginia, United States
URL: https://clinicaltrials.gov/show/NCT00997152

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress